Optogenetic Characterization and Control of Stem Cell Signaling
干细胞信号传导的光遗传学表征和控制
基本信息
- 批准号:9000181
- 负责人:
- 金额:$ 33.98万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2014
- 资助国家:美国
- 起止时间:2014-02-15 至 2019-01-31
- 项目状态:已结题
- 来源:
- 关键词:AdultAgonistBiochemicalBiosensorCell AdhesionCell Surface ReceptorsCell physiologyCellsCellular biologyComplexCouplingDependencyDevelopmentDisease modelElectrophysiology (science)EmbryoEngineeringEnzymesEphrin-B2EphrinsFluorescence Resonance Energy TransferFutureHealthImplantInvestigationIon ChannelKnowledgeLearningLifeLigandsLightMediatingMemoryMethodsMicroscopyNamesNatureNeurogliaNeurologicNeuronal DifferentiationNeuronsOrganPathway interactionsPatientsPhotoreceptorsProcessPropertyProteinsPublic HealthReceptor ActivationRegenerative MedicineRegulationReplacement TherapyResearchResolutionRoleSignal InductionSignal PathwaySignal TransductionStem cellsSystemTechniquesTimeTissuesWorkbasecell behaviorcell motilitycellular engineeringcryptochrome 2designembryonic stem cellfluorescence imaginghuman diseaseinduced pluripotent stem cellinsightlive cell imagingmood regulationnanoscalenerve stem cellneurogenesisnoveloptogeneticsrhorho GTP-Binding Proteinsself-renewalsensorsingle moleculestem cell biologystem cell differentiationstem cell divisionstem cell fatetissue regenerationtool
项目摘要
DESCRIPTION: The objective of the proposed work is to use optogenetics to investigate key signaling pathways - Wnt and Rho - in adult neural stem cells (NSCs) and embryonic stem cells (ESCs). Stem cells are being broadly explored for their potential for tissue regeneration, including strategies to manipulate endogenous stem cells residing within a patient's tissues (e.g., adult neural stem cells) as well as to implant exogenously cultured stem cells (e.g., embryonic or induced pluripotent stem cells) or their differentiated progeny. However, basic knowledge of the signaling mechanisms that control stem cell self-renewal and differentiation is currently incomplete, which limits our understanding of their role in adult function and complicates efforts to precisely control stem cell behavior for regenerative medicine applications. Light is a powerful tool to investigate cellular function. In particular, the abilityto modulate the Wnt and Rho signaling pathways spatially and temporally would allow us to elucidate their role in controlling stem cell fate, which is critical for biomedical applications. o this end, we recently developed optogenetic methods that enable a light input to be channeled into several defined signaling pathways through the assembly of nanoscale signaling complexes. Specifically, we engineered a photo-activatable agonist of the canonical Wnt signaling pathway as well as the RhoA pathway. We also have the ability to use microscopy techniques to conduct single molecule fluorescent imaging at nanoscale resolutions and to use biosensors based on fluorescence resonance energy transfer (FRET) to characterize Rho GTPase activities in live cells in real time. The first aim of the proposed work is to determine whether optogenetic activation of Wnt/¿-catenin signaling in NSCs and ESCs can elucidate mechanisms of stem cell regulation. The second aim is to use optogenetics to probe Rho GTPase signaling and crosstalk in NSCs. The third aim is to determine whether Cry2 can be engineered for cell surface receptor activation and for multiplexed stimulation of cellular signaling. We anticipate that applying our novel optogenetic approaches will elucidate the dynamic roles of the Wnt and Rho pathways in regulating cell fate choices in NSCs and ESCs. Moreover, the novel optogenetic methods that we will develop will further enhance future investigations of key signaling pathways in cell and stem cell biology. The resulting mechanistic insights into stem cell biology and engineering will greatly impact approaches to restore organ function based on cell replacement and regenerative medicine.
产品说明:这项工作的目的是利用光遗传学研究成体神经干细胞(NSCs)和胚胎干细胞(ESCs)中的关键信号通路- Wnt和Rho。干细胞因其组织再生的潜力而被广泛探索,包括操纵驻留在患者组织内的内源性干细胞的策略(例如,成体神经干细胞)以及植入外源培养的干细胞(例如,胚胎或诱导的多能干细胞)或它们的分化后代。然而,控制干细胞自我更新和分化的信号传导机制的基本知识目前还不完整,这限制了我们对它们在成人功能中的作用的理解,并使精确控制干细胞行为用于再生医学应用的努力变得复杂。光是研究细胞功能的有力工具。特别是,在空间和时间上调节Wnt和Rho信号通路的能力将使我们能够阐明它们在控制干细胞命运中的作用,这对于生物医学应用至关重要。为此,我们最近开发了光遗传学方法,该方法能够通过组装纳米级信号复合物将光输入引导到几个确定的信号通路中。具体而言,我们设计了经典Wnt信号通路以及RhoA通路的光活化激动剂。我们也有能力使用显微镜技术进行单分子荧光成像在纳米级的分辨率和使用生物传感器的荧光共振能量转移(FRET)的基础上表征Rho GTdR活性活细胞中的真实的时间。这项工作的第一个目的是确定神经干细胞和胚胎干细胞中Wnt/β-连环蛋白信号的光遗传学激活是否可以阐明干细胞调控的机制。第二个目的是使用光遗传学来探测NSC中的Rho GT3信号传导和串扰。第三个目的是确定Cry 2是否可以被工程化用于细胞表面受体活化和用于细胞信号传导的多重刺激。我们预计,应用我们的新型光遗传学方法将阐明Wnt和Rho通路在调节神经干细胞和胚胎干细胞的细胞命运选择中的动态作用。此外,我们将开发的新型光遗传学方法将进一步加强未来对细胞和干细胞生物学中关键信号通路的研究。由此产生的对干细胞生物学和工程学的机械见解将极大地影响基于细胞替代和再生医学的恢复器官功能的方法。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Ravi S. Kane其他文献
Multivalent S2 subunit vaccines provide broad protection against Clade 1 sarbecoviruses in female mice
多价 S2 亚单位疫苗为雌性小鼠提供了针对第 1 群沙贝科病毒的广泛保护
- DOI:
10.1038/s41467-025-55824-y - 发表时间:
2025-01-07 - 期刊:
- 影响因子:15.700
- 作者:
Peter J. Halfmann;Raj S. Patel;Kathryn Loeffler;Atsuhiro Yasuhara;Lee-Ann Van De Velde;Jie E. Yang;Jordan Chervin;Chloe Troxell;Min Huang;Naiying Zheng;Elizabeth R. Wright;Paul G. Thomas;Patrick C. Wilson;Yoshihiro Kawaoka;Ravi S. Kane - 通讯作者:
Ravi S. Kane
Enzyme-based formulations for decontamination: current state and perspectives
- DOI:
10.1007/s00253-013-4797-x - 发表时间:
2013-03-10 - 期刊:
- 影响因子:4.300
- 作者:
Navdeep Grover;Cerasela Zoica Dinu;Ravi S. Kane;Jonathan S. Dordick - 通讯作者:
Jonathan S. Dordick
Facile generation of drug-like conformational antibodies specific for amyloid fibrils
针对淀粉样纤维的类药物构象抗体的简便生成
- DOI:
10.1038/s41589-025-01881-9 - 发表时间:
2025-04-29 - 期刊:
- 影响因子:13.700
- 作者:
Alec A. Desai;Jennifer M. Zupancic;Hanna Trzeciakiewicz;Julia E. Gerson;Kelly N. DuBois;Mary E. Skinner;Lisa M. Sharkey;Nikki McArthur;Sean P. Ferris;Nemil N. Bhatt;Emily K. Makowski;Matthew D. Smith;Hongwei Chen;Jie Huang;Cynthia Jerez;Yun-Huai Kuo;Ravi S. Kane;Nicholas M. Kanaan;Henry L. Paulson;Peter M. Tessier - 通讯作者:
Peter M. Tessier
Ravi S. Kane的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Ravi S. Kane', 18)}}的其他基金
Engineering Protein Antigens and their Presentation from Multivalent Scaffolds
工程蛋白质抗原及其从多价支架的呈现
- 批准号:
10582942 - 财政年份:2023
- 资助金额:
$ 33.98万 - 项目类别:
Design and Evolution of Polyvalent Domain Antibodies Specific for Tau Aggregates
Tau 聚集体特异性多价域抗体的设计和进化
- 批准号:
10585480 - 财政年份:2018
- 资助金额:
$ 33.98万 - 项目类别:
Engineering Nanoscale Aptamer-based Biomaterials that Target Cellular Receptors
针对细胞受体的工程纳米适体生物材料
- 批准号:
9112133 - 财政年份:2015
- 资助金额:
$ 33.98万 - 项目类别:
Optogenetic Characterization and Control of Stem Cell Signaling
干细胞信号传导的光遗传学表征和控制
- 批准号:
8674874 - 财政年份:2014
- 资助金额:
$ 33.98万 - 项目类别:
Optogenetic Characterization and Control of Stem Cell Signaling
干细胞信号传导的光遗传学表征和控制
- 批准号:
9208064 - 财政年份:2014
- 资助金额:
$ 33.98万 - 项目类别:
Engineering Nanoscale Aptamer-based Biomaterials that Target Cellular Receptors
针对细胞受体的工程纳米适体生物材料
- 批准号:
8523855 - 财政年份:2012
- 资助金额:
$ 33.98万 - 项目类别:
Engineering Nanoscale Aptamer-based Biomaterials that Target Cellular Receptors
针对细胞受体的工程纳米适体生物材料
- 批准号:
8345177 - 财政年份:2012
- 资助金额:
$ 33.98万 - 项目类别:
Engineering Nanoscale Aptamer-based Biomaterials that Target Cellular Receptors
针对细胞受体的工程纳米适体生物材料
- 批准号:
8711082 - 财政年份:2012
- 资助金额:
$ 33.98万 - 项目类别:
相似国自然基金
Agonist-GPR119-Gs复合物的结构生物学研究
- 批准号:32000851
- 批准年份:2020
- 资助金额:24.0 万元
- 项目类别:青年科学基金项目
相似海外基金
S1PR1 agonistによる脳血液関門制御を介した脳梗塞の新規治療法開発
S1PR1激动剂调节血脑屏障治疗脑梗塞新方法的开发
- 批准号:
24K12256 - 财政年份:2024
- 资助金额:
$ 33.98万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
AHR agonistによるSLE皮疹の新たな治療薬の開発
使用 AHR 激动剂开发治疗 SLE 皮疹的新疗法
- 批准号:
24K19176 - 财政年份:2024
- 资助金额:
$ 33.98万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Evaluation of a specific LXR/PPAR agonist for treatment of Alzheimer's disease
特定 LXR/PPAR 激动剂治疗阿尔茨海默病的评估
- 批准号:
10578068 - 财政年份:2023
- 资助金额:
$ 33.98万 - 项目类别:
AUGMENTING THE QUALITY AND DURATION OF THE IMMUNE RESPONSE WITH A NOVEL TLR2 AGONIST-ALUMINUM COMBINATION ADJUVANT
使用新型 TLR2 激动剂-铝组合佐剂增强免疫反应的质量和持续时间
- 批准号:
10933287 - 财政年份:2023
- 资助金额:
$ 33.98万 - 项目类别:
Targeting breast cancer microenvironment with small molecule agonist of relaxin receptor
用松弛素受体小分子激动剂靶向乳腺癌微环境
- 批准号:
10650593 - 财政年份:2023
- 资助金额:
$ 33.98万 - 项目类别:
AMPKa agonist in attenuating CPT1A inhibition and alcoholic chronic pancreatitis
AMPKa 激动剂减轻 CPT1A 抑制和酒精性慢性胰腺炎
- 批准号:
10649275 - 财政年份:2023
- 资助金额:
$ 33.98万 - 项目类别:
Investigating mechanisms underpinning outcomes in people on opioid agonist treatment for OUD: Disentangling sleep and circadian rhythm influences on craving and emotion regulation
研究阿片类激动剂治疗 OUD 患者结果的机制:解开睡眠和昼夜节律对渴望和情绪调节的影响
- 批准号:
10784209 - 财政年份:2023
- 资助金额:
$ 33.98万 - 项目类别:
A randomized double-blind placebo controlled Phase 1 SAD study in male and female healthy volunteers to assess safety, pharmacokinetics, and transient biomarker changes by the ABCA1 agonist CS6253
在男性和女性健康志愿者中进行的一项随机双盲安慰剂对照 1 期 SAD 研究,旨在评估 ABCA1 激动剂 CS6253 的安全性、药代动力学和短暂生物标志物变化
- 批准号:
10734158 - 财政年份:2023
- 资助金额:
$ 33.98万 - 项目类别:
A novel nanobody-based agonist-redirected checkpoint (ARC) molecule, aPD1-Fc-OX40L, for cancer immunotherapy
一种基于纳米抗体的新型激动剂重定向检查点 (ARC) 分子 aPD1-Fc-OX40L,用于癌症免疫治疗
- 批准号:
10580259 - 财政年份:2023
- 资助金额:
$ 33.98万 - 项目类别:
Identification and characterization of a plant growth promoter from wild plants: is this a novel plant hormone agonist?
野生植物中植物生长促进剂的鉴定和表征:这是一种新型植物激素激动剂吗?
- 批准号:
23K05057 - 财政年份:2023
- 资助金额:
$ 33.98万 - 项目类别:
Grant-in-Aid for Scientific Research (C)